Project REGAIN – I5Q-MC-CGAI

Basic data

Acronym:
REGAIN
Title:
I5Q-MC-CGAI
Duration:
25/11/2015 to 24/11/2017
Abstract / short description:
A phase 3, randomized, double-blind, placebo-controlled study of LY2951742 in patients with chronic migraine - the REGAIN study.

Involved staff

Managers

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Basingstoke, Hampshire, United Kingdom
Help

will be deleted permanently. This cannot be undone.